Introduction Gardasil is a vaccine created to prevent human papillomavirus (HPV) infections which can lead to cervical cancer and genital warts. The vaccine is produced by Merck & Co. and is administered in three doses to female and male individuals, specifically ages 9 to 45. The vaccine has been approved by the US Food and Drug Administration (FDA) for more than a decade and is endorsed by the Centers for Disease Control and Prevention (CDC). Uses Gardasil is an HPV vaccine that works to prevent infections that can lead to cancer and genital warts. The vaccine is recommended for both females and males, ages 9 to 45, who are at risk of HPV infection. The vaccine is effective against several types of HPV, including those that cause genital warts and the majority of HPV types that cause cervical cancer. Dosage Gardasil is administered in three doses over a period of six months. The first dose is given at the start of the vaccination series, the second dose is given two months later, and the final dose is given six months after the first dose. The vaccine can be administered to both females and males, ages 9 to 45, and should be given by a healthcare professional. Demographic The demographic for Gardasil is for individuals who are at risk of HPV infection. The vaccine is recommended for females and males, ages 9 to 45, and can be administered to those who have not already been exposed to HPV. The vaccine is recommended for preteens and young adults before they become sexually active. Side Effects The most commonly reported side effects of Gardasil are mild and include pain, redness, or swelling at the injection site, headache, fever, and nausea. In rare cases, individuals may experience more severe side effects, such as a severe allergic reaction. Interactions There are no known interactions between Gardasil and other medications or vaccines. However, individuals should inform their healthcare provider of any medications they are taking before receiving the vaccine. Generic Options Currently, there are no generic versions of Gardasil available on the market. However, the HPV vaccine Cervarix is similar to Gardasil and is also used to prevent HPV infections. Cervarix is produced by GlaxoSmithKline and is approved for use in females ages 9 to 26. Conclusion Gardasil is a vaccine used to prevent HPV infections and is recommended for both females and males, ages 9 to 45. The vaccine is administered in three doses over a period of six months and can be administered by a healthcare professional. While the vaccine can cause mild side effects, it is generally safe and effective in preventing HPV infections. Individuals should inform their healthcare provider of any medications they are taking before receiving the vaccine. Currently, there are no generic versions of Gardasil available, but the HPV vaccine Cervarix is similar and is also used to prevent HPV infections in females.